132 related articles for article (PubMed ID: 16447780)
21. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
[TBL] [Abstract][Full Text] [Related]
22. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
Yamashita T; Kwak S
Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the AMPA-activated receptors present on motoneurons.
Greig A; Donevan SD; Mujtaba TJ; Parks TN; Rao MS
J Neurochem; 2000 Jan; 74(1):179-91. PubMed ID: 10617119
[TBL] [Abstract][Full Text] [Related]
24. Developmental characteristics of AMPA receptors in chick lumbar motoneurons.
Ni X; Sullivan GJ; Martin-Caraballo M
Dev Neurobiol; 2007 Sep; 67(11):1419-32. PubMed ID: 17497695
[TBL] [Abstract][Full Text] [Related]
25. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia.
Peng PL; Zhong X; Tu W; Soundarapandian MM; Molner P; Zhu D; Lau L; Liu S; Liu F; Lu Y
Neuron; 2006 Mar; 49(5):719-33. PubMed ID: 16504947
[TBL] [Abstract][Full Text] [Related]
26. Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS.
Sasaki S; Yamashita T; Kwak S
Neurosci Lett; 2015 Jun; 598():79-84. PubMed ID: 25980994
[TBL] [Abstract][Full Text] [Related]
27. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
28. GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis.
Laslo P; Lipski J; Nicholson LF; Miles GB; Funk GD
Exp Neurol; 2001 Jun; 169(2):461-71. PubMed ID: 11358459
[TBL] [Abstract][Full Text] [Related]
29. Editing of GluR2 RNA in the gerbil hippocampus after global cerebral ischemia.
Rump A; Sommer C; Gass P; Bele S; Meissner D; Kiessling M
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1362-5. PubMed ID: 8898712
[TBL] [Abstract][Full Text] [Related]
30. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
Hosaka T; Tsuji H; Kwak S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
[TBL] [Abstract][Full Text] [Related]
31. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity.
Van Damme P; Bogaert E; Dewil M; Hersmus N; Kiraly D; Scheveneels W; Bockx I; Braeken D; Verpoorten N; Verhoeven K; Timmerman V; Herijgers P; Callewaert G; Carmeliet P; Van Den Bosch L; Robberecht W
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14825-30. PubMed ID: 17804792
[TBL] [Abstract][Full Text] [Related]
32. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
Kwak S
Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
[TBL] [Abstract][Full Text] [Related]
33. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons.
Whitney NP; Peng H; Erdmann NB; Tian C; Monaghan DT; Zheng JC
FASEB J; 2008 Aug; 22(8):2888-900. PubMed ID: 18403631
[TBL] [Abstract][Full Text] [Related]
34. [AMPA receptor-mediated neuronal death and amyotrophic lateral sclerosis].
Hideyama T; Kawahara Y; Kwak S
No To Shinkei; 2005 Jul; 57(7):585-98. PubMed ID: 16095220
[No Abstract] [Full Text] [Related]
35. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
[TBL] [Abstract][Full Text] [Related]
36. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
[TBL] [Abstract][Full Text] [Related]
37. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
[TBL] [Abstract][Full Text] [Related]
38. Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing.
Krampfl K; Schlesinger F; Zörner A; Kappler M; Dengler R; Bufler J
Eur J Neurosci; 2002 Jan; 15(1):51-62. PubMed ID: 11860506
[TBL] [Abstract][Full Text] [Related]
39. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain.
Kawahara Y; Ito K; Sun H; Kanazawa I; Kwak S
Eur J Neurosci; 2003 Jul; 18(1):23-33. PubMed ID: 12859334
[TBL] [Abstract][Full Text] [Related]
40. Editing status at the Q/R site of the GluR2 and GluR6 glutamate receptor subunits in the surgically excised hippocampus of patients with refractory epilepsy.
Grigorenko EV; Bell WL; Glazier S; Pons T; Deadwyler S
Neuroreport; 1998 Jul; 9(10):2219-24. PubMed ID: 9694203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
